Disease progression modelling from preclinical Alzheimer’s disease (AD) to AD dementia
Soo Hyun Cho(Samsung Medical Center), Sang Won Seo(Sungkyunkwan University), Byeong C. Kim(Chonnam National University Hospital), Duk L. Na(Samsung Medical Center), Rik Ossenkoppele(Malmö University), Si Eun Kim(Changwon National University), Samuel N. Lockhart(Wake Forest University), Hyemin Jang(Ulsan College), Young Hee Jung(Samsung Medical Center), Susan Landau(University of California, Berkeley), Hee Jin Kim(Gyeongsang National University), Changsoo Kim(Institute of Nanotechnology), Seung Joo Kim(Changwon National University), Michael W. Weiner(University of California, San Francisco), Sook‐Young Woo(Samsung (South Korea)), Seonwoo Kim(University of Ulsan), Jun Pyo Kim
Cited by 38
Related Papers
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
|Brain|2016|1.2k
Vascular dysfunction—The disregarded partner of Alzheimer's disease
|Alzheimer s & Dementia|2019|721
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
|Alzheimer s & Dementia|2018|690